share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Dubovsky Filip

SEC announcement ·  Mar 26 19:05
Summary by Moomoo AI
Filip Dubovsky, President of R&D at Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the company's stock performance.
Filip Dubovsky, President of R&D at Novavax Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Novavax, which could potentially influence the company's stock performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more